Column Group L P is Director of NGM BIOPHARMACEUTICALS INC. Currently has a direct ownership of 0 shares of NGM, which is worth approximately $0. The most recent transaction as insider was on Oct 09, 2019, when has been sold 17,724 shares (Common Stock) at a price of $10.26 per share, resulting in proceeds of $181,848. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 0
100.0% 3M change
100.0% 12M change
Total Value Held $0

COLUMN GROUP L P Transaction History

Date Transaction Value Shares Traded Shares Held Form
Oct 09 2019
BUY
Open market or private purchase
$181,848 $10.26 p/Share
17,724 Added 50.0%
17,724 Common Stock
Aug 09 2019
BUY
Open market or private purchase
$2,126 $13.99 p/Share
152 Added 0.01%
2,597,816 Common Stock
Aug 08 2019
BUY
Open market or private purchase
$168 $13.98 p/Share
12 Added 0.0%
2,597,664 Common Stock
Aug 07 2019
BUY
Open market or private purchase
$3,143,000 $14.0 p/Share
224,500 Added 7.95%
2,597,652 Common Stock
Aug 06 2019
BUY
Open market or private purchase
$4,328 $13.96 p/Share
310 Added 0.01%
2,373,152 Common Stock
Aug 05 2019
BUY
Open market or private purchase
$81,420 $13.98 p/Share
5,824 Added 0.24%
2,372,842 Common Stock
Aug 02 2019
BUY
Open market or private purchase
$24,895 $13.97 p/Share
1,782 Added 0.08%
2,367,018 Common Stock
Aug 01 2019
BUY
Open market or private purchase
$36,348 $13.98 p/Share
2,600 Added 0.11%
2,365,236 Common Stock
Jul 30 2019
BUY
Open market or private purchase
$123,173 $13.91 p/Share
8,855 Added 0.37%
2,362,636 Common Stock
Jul 29 2019
BUY
Open market or private purchase
$260,750 $13.58 p/Share
19,201 Added 0.81%
2,353,781 Common Stock
Jul 26 2019
BUY
Open market or private purchase
$408,502 $13.59 p/Share
30,059 Added 1.27%
2,334,580 Common Stock
Jul 25 2019
BUY
Open market or private purchase
$411,168 $13.37 p/Share
30,753 Added 1.32%
2,304,521 Common Stock
Jul 24 2019
BUY
Open market or private purchase
$392,520 $13.51 p/Share
29,054 Added 1.26%
2,273,768 Common Stock
Jul 23 2019
BUY
Open market or private purchase
$410,646 $13.35 p/Share
30,760 Added 1.35%
2,244,714 Common Stock
Jul 22 2019
BUY
Open market or private purchase
$416,490 $13.54 p/Share
30,760 Added 1.37%
2,213,954 Common Stock
Jul 19 2019
BUY
Open market or private purchase
$87,046 $13.99 p/Share
6,222 Added 0.28%
2,183,194 Common Stock
Jul 16 2019
BUY
Open market or private purchase
$54,054 $13.86 p/Share
3,900 Added 0.18%
2,176,972 Common Stock
Jul 15 2019
BUY
Open market or private purchase
$221,614 $13.69 p/Share
16,188 Added 0.74%
2,173,072 Common Stock
Jul 12 2019
BUY
Open market or private purchase
$291,674 $13.88 p/Share
21,014 Added 0.96%
2,156,884 Common Stock
Jul 11 2019
BUY
Open market or private purchase
$150,767 $13.87 p/Share
10,870 Added 0.51%
2,135,870 Common Stock
Jun 24 2019
BUY
Open market or private purchase
$168,667 $13.78 p/Share
12,240 Added 0.57%
2,125,000 Common Stock
Jun 21 2019
BUY
Open market or private purchase
$52,795 $14.03 p/Share
3,763 Added 0.18%
2,112,760 Common Stock
Jun 20 2019
BUY
Open market or private purchase
$213,444 $13.86 p/Share
15,400 Added 0.72%
2,108,997 Common Stock
Jun 19 2019
BUY
Open market or private purchase
$211,627 $13.91 p/Share
15,214 Added 0.72%
2,093,597 Common Stock
Jun 14 2019
BUY
Open market or private purchase
$150,640 $14.0 p/Share
10,760 Added 0.52%
2,078,383 Common Stock

Also insider at

IMDZ
IMMUNE DESIGN CORP.
CNST
CONSTELLATION PHARMACEUTICALS INC Healthcare
NRIX
Nurix Therapeutics, Inc. Healthcare
CGL

Column Group L P

Director
San Francisco, CA

Track Institutional and Insider Activities on NGM

Follow NGM BIOPHARMACEUTICALS INC and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells NGM shares.

Notify only if

Insider Trading

Get notified when an Ngm Biopharmaceuticals Inc insider buys or sells NGM shares.

Notify only if

News

Receive news related to NGM BIOPHARMACEUTICALS INC

Track Activities on NGM